Influence of common p53 and XRCC1 variant alleles on risk of lung cancer

P. A. Gervas, N. A. Smetannikova, A. Y. Dobrodeev, S. V. Miller, S. A. Tusikov, V. A. Belyavskaya, N. V. Cherdyntseva (Tomsk, Novosibirsk, Russian Federation)

Source: Annual Congress 2006 - Genetics in lung cancer
Session: Genetics in lung cancer
Session type: Electronic Poster Discussion
Number: 4681

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. A. Gervas, N. A. Smetannikova, A. Y. Dobrodeev, S. V. Miller, S. A. Tusikov, V. A. Belyavskaya, N. V. Cherdyntseva (Tomsk, Novosibirsk, Russian Federation). Influence of common p53 and XRCC1 variant alleles on risk of lung cancer. Eur Respir J 2006; 28: Suppl. 50, 4681

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Combined effect of p53 and XRCC1 gene polymorphisms on age-associated lung cancer risk
Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics
Year: 2008



Arg72Pro and GSTM1 gene polymorphisms increase the risk of non small cell lung cancer (NSCLC)
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

TP53 Arg72Pro, GSTM1, GSTP1 Ile105Val and GSTT1 gene polymorphisms as predisposing factors for non-small cell lung cancer (NSCLC) development
Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer
Year: 2006


Analysis of XPD gene Lys751Gln polymorphism as predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2007; 30: Suppl. 51, 131s
Year: 2007

Evaluation of EGFR mutations and ERCC2 polymorphisms in treatment of non-small cell lung cancer
Source: Annual Congress 2005 - Chemotherapy and palliative care
Year: 2005


Association of -93G®A polymorphism in the hMLH1 gene with susceptibility to and prognosis of non-small cell lung cancer in Taiwan
Source: Eur Respir J 2006; 28: Suppl. 50, 151s
Year: 2006

Arg72Pro P53 gene polymorphism as a predisposing factor for non-small cell lung cancer (NSCLC) development
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Association of polymorphism of the human nm23-H1 gene (NME1) with susceptibility to and severity of non-small cell lung cancer
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Polymorphism in GSTM1, GSTT1, p53 and CCR5 genes and lung cancer progression: relation to p53 and Ki-67 protein expression in tumors of non-small cell lung cancer patients
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006

XRCC1 Arg194Trp and Arg399Gln polymorphisms and lung cancer risk in Romanian population
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

The influence of the polymorphism at codon 72 of exon 4 of the P53 gene and GSTM1 and GSTT1 null in lung cancer risk in a Brazilian population
Source: Eur Respir J 2006; 28: Suppl. 50, 812s
Year: 2006

CYP1A1 polymorphisms and risk of lung cancer in a Brazilian population
Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases
Year: 2008

P53 protein expression and polymorphism of GSTT1 and GSTM1 genes in central lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006

p53 gene mutations in lung cancer in Korean
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005

Genotyping single-nucleotide polymorphisms (SNP) in ERCC1, XPD, XRCC1, XRCC3 and MDR-1 and CCND-1 genes for response and toxicity prediction in chemotherapy of non small cell lung cancer (NSCLC)
Source: Annual Congress 2007 - Biology in thoracic oncology
Year: 2007


Association of XPD and CDA polymorphisms with clinical outcome in non-small cell lung cancer in a Chinese population
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Polymorphisms A1026G and G369C of CDKN1A/p21 and p53 genes in lung cancer
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

Polymorphisms in telomere maintenance genes and risk of lung cancer
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



The effect of polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) on lung cancer outcome
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005